InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Browse the complete record of transactions filed by Norry Elliot. Insider active across 1 company, notably Adaptimmune Therapeutics PLC. Cumulatively, 6 filings have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €42k. History available since 4 January 2022. The latest transaction was disclosed on 18 January 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
2,121 shares@ US$3.191814.2% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-005054:0
2,121 shares@ US$3.191828.5% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-005054
3,770 shares@ US$3.556756.8% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-004150
3,770 shares@ US$3.556728.4% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-004150:0
849 shares@ US$4.064214.7% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-001669
849 shares@ US$4.06427.3% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-001669:0
6 of 6 declarations
About Norry Elliot
Norry Elliot is a director at Adaptimmune Therapeutics PLC.
